CEP55 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma via the PI3K/Akt pathway

References

• SiegelRNaishadhamDJemalACancer statistics, 2012CA Cancer J Clin2012621102922237781
   PubMed Web of Science ®Google Scholar
• NapierKJScheererMMisraSEsophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalitiesWorld J Gastrointest Oncol20146511212024834141
   PubMed Web of Science ®Google Scholar
• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• KamangarFDoresGMAndersonWFPatterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the worldJ Clin Oncol200624142137215016682732
   PubMed Web of Science ®Google Scholar
• EloubeidiMADesmondRArguedasMRReedCEWilcoxCMPrognostic factors for the survival of patients with esophageal carcinoma in the U.SCancer20029571434144312237911
   PubMed Web of Science ®Google Scholar
• JefferyJSinhaDSrihariSKalimuthoMKhannaKKBeyond cytokinesis: the emerging roles of CEP55 in tumorigenesisOncogene201635668369025915844
   PubMed Web of Science ®Google Scholar
• PengTZhouWGuoFCentrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressivenessSci Rep201771592528724890
   PubMed Web of Science ®Google Scholar
• WangGLiuMWangHCentrosomal Protein of 55 Regulates Glucose Metabolism, Proliferation and Apoptosis of Glioma Cells via the Akt/mTOR Signaling PathwayJ Cancer20167111431144027471559
   PubMed Web of Science ®Google Scholar
• TaoJZhiXTianYCEP55 contributes to human gastric carcinoma by regulating cell proliferationTumour Biol20143554389439924390615
   PubMedGoogle Scholar
• WaseemAAliMOdellEWFortuneFTehMTDownstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinomaOral Oncol201046753654220400365
   PubMed Web of Science ®Google Scholar
• ChenCHChienCYHuangCCExpression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activityOncogene200928302723273719525975
   PubMed Web of Science ®Google Scholar
• ChenCHShiuLYSuLJFLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathwayJ Transl Med2012109322591637
   PubMed Web of Science ®Google Scholar
• ChenCHLuPJChenYCFLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathwayOncogene200726294272428317237822
   PubMed Web of Science ®Google Scholar
• WangYJinTDaiXXuJLentivirus-mediated knockdown of CEP55 suppresses cell proliferation of breast cancer cellsBiosci Trends2016101677326902787
   PubMed Web of Science ®Google Scholar
• ChenCHLaiJMChouTYVEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via PI3K/AKT pathwayPLoS One200944e505219337377
   PubMed Web of Science ®Google Scholar
• ZhangWNiuCHeWUpregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinomaTumour Biol20163756239625426615423
   PubMedGoogle Scholar
• CoutantCRouzierRQiYDistinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancersClin Cancer Res20111782591260121248301
   PubMed Web of Science ®Google Scholar
• JonesJOtuHSpentzosDGene signatures of progression and metastasis in renal cell cancerClin Cancer Res200511165730573916115910
   PubMed Web of Science ®Google Scholar
• HuYWuGRuschMIntegrated cross-species transcriptional network analysis of metastatic susceptibilityProc Natl Acad Sci U S A201210983184318922308418
   PubMed Web of Science ®Google Scholar
• CuzickJSwansonGPFisherGPrognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective studyLancet Oncol201112324525521310658
   PubMed Web of Science ®Google Scholar
• HennessyBTSmithDLRamPTLuYMillsGBExploiting the PI3K/AKT pathway for cancer drug discoveryNat Rev Drug Discov2005412988100416341064
   PubMed Web of Science ®Google Scholar
• LiuPChengHRobertsTMZhaoJJTargeting the phosphoinositide 3-kinase pathway in cancerNat Rev Drug Discov20098862764419644473
   PubMed Web of Science ®Google Scholar
• MccubreyJASteelmanLSChappellWHAdvances in targeting signal transduction pathwaysOncotarget20123121505152123455493
   PubMedGoogle Scholar
• LiuMHuYZhangMFMMP1 promotes tumor growth and metastasis in esophageal squamous cell carcinoma2016377197104
   Google Scholar
• NieZCWengWHShangYSMicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathwayInt J Clin Exp Pathol2015854745475426191164
   PubMed Web of Science ®Google Scholar
• ChenJLanTZhangWPlatelet-activating factor receptor-mediated PI3K/AKT activation contributes to the malignant development of esophageal squamous cell carcinomaOncogene201534405114512725639872
   PubMed Web of Science ®Google Scholar
• ChenGWangZLiuXYLiuFYAdjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?Ann Thorac Surg20098761697170219463580
   PubMed Web of Science ®Google Scholar
• JiaYZhangMJiangWZhangZHuangSWangZOverexpression of IFITM3 predicts the high risk of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomyPeerJ20153e135526539332
   PubMed Web of Science ®Google Scholar
• JiangWWangZJiaYCEP55 overexpression predicts poor prognosis in patients with locally advanced esophageal squamous cell carcinomaOncol Lett201713123624228123547
   PubMed Web of Science ®Google Scholar
• StahlMMarietteCHaustermansKCervantesAArnoldDESMO Guidelines Working GroupOesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201324Suppl 6vi51vi5624078662
   PubMed Web of Science ®Google Scholar
• NakagawaSKandaTKosugiSOhashiMSuzukiTHatakeyamaKRecurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomyJ Am Coll Surg2004198220521114759776
   PubMed Web of Science ®Google Scholar
• LawSWongJTwo-field dissection is enough for esophageal cancerDis Esophagus20011429810311553217
   PubMed Web of Science ®Google Scholar
• HwangCFShiuLYSuLJOncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosisPLoS One2013812e8421824386352
   PubMed Web of Science ®Google Scholar
• ThieryJPAcloqueHHuangRYNietoMAEpithelial-mesenchymal transitions in development and diseaseCell2009139587189019945376
   PubMed Web of Science ®Google Scholar
• NietoMAEpithelial-Mesenchymal Transitions in development and disease: old views and new perspectivesInt J Dev Biol2009538–101541154719247945
   PubMed Web of Science ®Google Scholar
• KahataKDadrasMSMoustakasATGF-β Family Signaling in Epithelial Differentiation and Epithelial-Mesenchymal TransitionCold Spring Harb Perspect Biol2018101a02219428246184
   PubMed Web of Science ®Google Scholar
• da SilvaSDMorandGBAlobaidFAEpithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinomaClin Exp Metastasis2015321556325433796
   PubMed Web of Science ®Google Scholar
• GarsideVCChangACKarsanAHoodlessPACo-ordinating Notch, BMP, and TGF-β signaling during heart valve developmentCell Mol Life Sci201370162899291723161060
   PubMed Web of Science ®Google Scholar
• HemmingsBARestucciaDFThe PI3K-PKB/Akt pathwayCold Spring Harb Perspect Biol201574a02660925833846
   PubMed Web of Science ®Google Scholar
• ManningBDCantleyLCAKT/PKB signaling: navigating downstreamCell200712971261127417604717
   PubMed Web of Science ®Google Scholar
• MartiniMde SantisMCBracciniLGulluniFHirschEPI3K/AKT signaling pathway and cancer: an updated reviewAnn Med201446637238324897931
   PubMed Web of Science ®Google Scholar
• de LucaAMaielloMRD’AlessioAPergamenoMNormannoNThe RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approachesExpert Opin Ther Targets201216Suppl 2S17S27
   PubMed Web of Science ®Google Scholar
• YoshiokaAMiyataHDokiYThe activation of Akt during preoperative chemotherapy for esophageal cancer correlates with poor prognosisOncol Rep20081951099110718425364
   PubMed Web of Science ®Google Scholar
• LiuMHuYZhangMFMMP1 promotes tumor growth and metastasis in esophageal squamous cell carcinomaCancer Lett201637719710427130665
   PubMed Web of Science ®Google Scholar
• CheungMTestaJRDiverse mechanisms of AKT pathway activation in human malignancyCurr Cancer Drug Targets201313323424423297823
   PubMed Web of Science ®Google Scholar
• ChenGWangZLiuXYZhangMYLiuFYClinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagusEur J Cardiothorac Surg20093511718926712
   PubMed Web of Science ®Google Scholar
• YuYWangZYangZLiuXYTherapeutic efficacy evaluation of postoperative adjuvant radiotherapy in mid-thoracic esophageal carcinoma patients underwent Ivor Lewis esophagectomy with two-field lymphadenectomyMed Oncol201532234825572804
   PubMed Web of Science ®Google Scholar